:: HOME :: CONTACT US ::

COPYRIGHT MAXIMAX INTERNATIONAL 2002-2010

Welcome to MPR Development Group - a full service global Clinical Research and Development Organization, CRO. With a wide range of resources and expertise, we assist pharmaceutical and biotechnology companies efficiently to bring new therapies to people who need them. MPR consolidates therapeutic, operational and scientific capabilities of organizations and individuals who have been serving the health and bio-pharmaceutical industries for more than 30 years. Read more...

MPR launches global CRO strategic alliance. (PDF)

MPR to administer the emergency use of Peramivir under special regulatory approvals in selected countries.

MPR and Yamamoto launch an international research project on expanding the application of Hyperthermia in the treatment of several indications of cancer.

Full Service CRO Model:
MPR has the resources and capabilities to undertake most of clinical trial projects as a full service CRO and conducting them internationally. read more.
The FSP Model:
The Functional Service Provider Model, FSP, is ideal when Sponsors need only selected services or expand resources on existing capabilities. read more.
The Hybrid Model:
The Hybrid model emphasizes CRO/SMO support system in several international locations. read more.

• Home
• Our Services
  • Early Phases
  • Late Phases
  • Biometrics
    • Data Management
    • Bio-Statistics
    • Pharmacovigilance
    • Pharmacoeconomics
  • Regulatory
  • Bio-Equivalence
  • Resourcing
  • Commercialization
  • Risk Sharing
  • Innovative Solutions
• News & Events
• About us
  • Company History
  • Corporate Leadership
• Contact us
  • How to contact us
  • How we can help you!
  • Where we can help you!
• Partners
  • DCRC
  • CEE-RI
  • Maximax International
  • Maximax Venture